GLP-1 Drugs Put $149 Billion in Food Spending at Risk. So Far, the Biggest Loser Isn’t Candy

Approximately one in eight U.S. adults is currently taking a GLP-1 drug. Usage is reshaping one of the country’s biggest industries.